|
Age and Diet: Major interacting factors that drive sporadic intestinal cancer
|
5R01CA174432-05
|
$660,173
|
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Novel Androgen Receptor Degraders to Treat Castration-Resistant Prostate Cancer
|
5R44CA203199-02
|
$402,226
|
|
TAYLOR, IAN
|
ARVINAS, INC.
|
|
Managing chemotherapy induced neuropathy in Cancer patients using ExerGaming
|
5R21CA190933-02
|
$199,119
|
|
NAJAFI, BIJAN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Metabolic Regulation in Leukemia-Initatiating Cells
|
5R01CA193235-03
|
$462,191
|
|
NAKADA, DAISUKE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Training Healthcare Professionals to Implement Biopsychosocial Screening
|
5R25CA174444-05
|
$277,797
|
|
LOSCALZO, MATTHEW
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Novel RNA-Directed Therapy for the Treatment of Acute Myeloid Leukemia
|
5R01CA201496-02
|
$463,530
|
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cbx-3/HP-1gamma deficiency confers anti-tumor immunity
|
5R21CA198263-02
|
$225,765
|
|
THAI, TO-HA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Development of diagnostic and prognostic tests for esophageal adenocarcinoma
|
1R01CA208599-01A1
|
$646,502
|
|
GODFREY, TONY
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Planning for NCDs Research Center of Excellence in Southern Africa
|
5P20CA210283-02
|
$236,966
|
$118,483
|
TAPELA, NEO
|
BOTSWANA-HARVARD AIDS INSTITUTE
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-04
|
$11,145,123
|
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
c-Abl-mediated Suppression of Breast Cancer Development and Metastasis
|
5R01CA177069-05
|
$328,265
|
|
SCHIEMANN, WILLIAM
|
CASE WESTERN RESERVE UNIVERSITY
|
|
INHIBITION OF A TREG DEUBIQUITINASE, USP7, PROMOTES ANTI-TUMOR IMMUNITY
|
5R01CA177852-03
|
$380,640
|
|
HANCOCK, WAYNE
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Modulation of MicroRNAs with Xenobiotics to Target c-Myc
|
5R01CA177810-03
|
$368,974
|
|
LI, YONG
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Cooperative steroidogenic inhibition for treatment of advanced prostate cancer
|
5R01CA168899-05
|
$326,897
|
|
SHARIFI, NIMA
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Cook For Your Life: Maintaining diet and physical activity changes in Latina breast cancer survivors
|
5R01CA186080-03
|
$597,551
|
|
GREENLEE, HEATHER
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Large-Scale Integration of Single Cell RNA-Seq and High-Content Imaging for Analyzing Drug Response in Cancer
|
5R33CA202827-02
|
$316,149
|
|
SIMS, PETER
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Mechanisms of Sensitivity to Cell Cycle Checkpoint Kinase Inhibitors
|
5R01CA117874-10
|
$298,566
|
|
EASTMAN, ALAN
|
DARTMOUTH COLLEGE
|
|
NCI National Clinical Trials Network U10
|
5U10CA180857-04
|
$392,946
|
|
CRAWFORD, JEFFREY
|
DUKE UNIVERSITY
|
|
Bidirectional role of KLF5 in prostatic epithelial homeostasis and tumorigenesis
|
5R01CA171189-05
|
$323,700
|
|
DONG, JIN-TANG
|
EMORY UNIVERSITY
|
|
Defining mechanisms of extracellular communication for cancer therapy
|
5R01CA163722-05
|
$323,700
|
|
VAN MEIR, ERWIN
|
EMORY UNIVERSITY
|
|
Regulation of MDM2 auto-ubiquitination and molecular targeting
|
5R01CA123490-10
|
$251,191
|
|
ZHOU, MUXIANG
|
EMORY UNIVERSITY
|
|
Improving treatment of cardiovascular risk factors in childhood cancer survivors
|
1R01CA204378-01A1
|
$773,174
|
$773,174
|
CHOW, ERIC
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-42S1
|
$249,999
|
$2,500
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-42S2
|
$125,000
|
$1,250
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-42S3
|
$58,085
|
$581
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-42S4
|
$70,220
|
$702
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
5P30CA015704-42
|
$9,559,285
|
$95,593
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
INFRASRUCTURE SUPPORT AND DATA ENHANCEMENTS FOR THE CARET BIOREPOSITORY
|
5UM1CA167462-05
|
$527,567
|
|
GOODMAN, GARY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Molecular Correlates of Outcomes in Clinical Trials of Colon Cancer
|
5R01CA176272-05
|
$571,758
|
|
NEWCOMB, POLLY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Impact of Park Renovations on Physical Activity and Community Health in NYC
|
7R01CA206877-02
|
$598,964
|
|
HUANG, TERRY
|
GRADUATE SCHOOL OF PUBLIC HEALTH AND HEALTH P
|
|
Genetic Epidemiology of Melanoma (GenoMel)
|
5R01CA083115-15
|
$574,390
|
|
KANETSKY, PETER
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
The Role of Driver Mutations in Lung Cancer Response to Anti-PD-1 Therapy
|
5F31CA196035-03
|
$31,579
|
|
GARRIS, CHRISTOPHER
|
HARVARD MEDICAL SCHOOL
|
|
Genetic Signatures Underlying Prostate Cancer Metastasis in AfricanAmericans
|
5R21CA199171-02
|
$131,370
|
|
FARUQUE, MEZBAH
|
HOWARD UNIVERSITY
|
|
Center/Coordination, Analysis and Management/MACS
|
UM1AI035043-25
|
$145,000
|
|
D'Souza, Gypsyamber
|
JOHNS HOPKINS UNIVERSITY
|
|
Validation and Fine-Scale Mapping of Pancreatic Cancer Susceptibility Loci (Study)
|
5R01CA154823-06
|
$646,350
|
|
KLEIN, ALISON
|
JOHNS HOPKINS UNIVERSITY
|
|
Ovarian cancer gene therapy using HPV pseudovirion
|
5R01CA183040-04
|
$336,150
|
|
WU, TZYY-CHOOU
|
JOHNS HOPKINS UNIVERSITY
|
|
Functions of Nonclassical Monocytes in the Vasculature
|
5R01CA202987-02
|
$450,481
|
|
HEDRICK, CATHERINE
|
LA JOLLA INST FOR ALLERGY & IMMUNOLGY
|
|
Chromatin organization as a predictor of stress induced immune dysregulation
|
5R01CA197005-02
|
$523,297
|
|
MATHEWS, HERBERT
|
LOYOLA UNIVERSITY CHICAGO
|
|
Increasing the diagnostic yield of low-risk bronchial biopsy in the evaluation of
|
5R01CA167827-05
|
$562,380
|
|
SUTER, MELISSA
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Understanding and Improving Platinum Anticancer Drugs
|
5R01CA034992-35
|
$674,719
|
|
LIPPARD, STEPHEN
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
HTS for Identification of Novel Inhibitors of Pyk2 Activity
|
5R01CA193382-03
|
$406,260
|
|
LOFTUS, JOSEPH
|
MAYO CLINIC ARIZONA
|
|
Classification of breast masses based on visco-elastic properties
|
5R01CA168575-05
|
$103,794
|
|
FATEMI, MOSTAFA
|
MAYO CLINIC ROCHESTER
|
|
Inhibition of Oral Tumorigenesis by Antitumor B
|
1R01CA205633-01A1
|
$525,681
|
|
YOU, MING
|
MEDICAL COLLEGE OF WISCONSIN
|
|
Integration of inflammation and cancer by molecular chaperone
|
1R01CA213290-01
|
$177,723
|
|
LI, ZIHAI
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,094,457
|
$43,778
|
Barr, Frederic
|
CCR (NCI)
|
|
Molecular Mechanism of Action of Phorbol Ester
|
ZIA BC 005270
|
$1,303,886
|
$65,194
|
Blumberg, Peter
|
CCR (NCI)
|
|
Insulin Resistance
|
ZIA CP010136-10798
|
$134,022
|
$67,011
|
Caporaso, Neil
|
DCEG (NCI)
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$474,811
|
$4,748
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Vascular Biology Section
|
ZIA BC 011390
|
$1,151,796
|
$287,949
|
Lin, Pengnian Charles
|
CCR (NCI)
|
|
Analysis of circulatory disease after low dose or low dose rate radiation exposur
|
ZIA CP010222-10738
|
$25,339
|
$12,669
|
Little, Mark
|
DCEG (NCI)
|
Total relevant funding to Vascular Disease for this search: $1,987,916
|